CopyFind
Serromac Plus Tablet
medicine 📍 IN

Serromac Plus Tablet

60,00 ₹

Analogs of Serromac Plus Tablet

Find cheaper analogs and generic equivalents for Serromac Plus Tablet.

Ingredients

Substancja czynna: Diclofenac; Paracetamol


Przegląd produktu

About Serromac Plus Tablet

Serromac Plus Tablet is a medication containing the active ingredient Diclofenac, classified as Nonsteroidal anti-inflammatory drug. Diclofenac, sold under the brand name Voltaren among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. It can be taken orally, inserted rectally as a suppository, injected intramuscularly, injected intravenously, applied to the skin topically, or throug….

Key Benefits & Uses

  • Used for: Uses for the temporary relief of arthritis pain ONLY in the following areas: hand, wrist, elbow (upper body areas) foot, ankle, knee (lower body.
  • Used for: it is not for immediate relief
  • Used for: If no pain relief in 7 days, stop use

Active Ingredient & Action

Diclofenac, the active ingredient in Serromac Plus Tablet, belongs to the Nonsteroidal anti-inflammatory drug class. Uses for the temporary relief of arthritis pain ONLY in the following areas: hand, wrist, elbow (upper body areas) foot, ankle, knee (lower body areas) this product may take up to 7 days to work for arthritis pain; it is not for immediate relief. If no pain relief in 7 days, stop use. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Serromac Plus Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Serromac Plus Tablet for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Serromac Plus Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.